Organizer
Regional hosts
Platinum Sponsors
Don’t miss a thing!
Subscribe to our newsletter and be the first to know.
About BIOSPAIN
BIOSPAIN is the largest biotech event organized by a national bioindustry association in Europe and one of the largest in the world by the number of one-to-one meetings and companies participating. 34% of our delegates came from outside of Spain.
This year, BIOSPAIN goes back to Barcelona, the main biotech cluster in Spain and one of the most dynamic cities in the world.
The event will take place in Pavilion 1 – Fira de Barcelona – Montjuïc. It stands in a superb location in the city center, easily accessible from the airport and well-connected to the public transport network. It is located in Montjuïc Park, an area of cultural and historical interest thanks to its museums and theatres and it also features some of the main tourist attractions in Barcelona.
BIOSPAN is the main biotechnology trade fair and conference in Spain and one of the largest in Europe.
BIOSPAIN 205 is part of the
Ways to participate
Register
as Delegate
as Delegate
Book a
Booth
Booth
Sponsor
the Event
the Event
Record result
Why Spain?
Nearly 4,500 companies carried out biotechnology activities in 2023, of which 974 were biotech firms.
47% of biotech firms working exclusively in biotechnology do so in human health, followed by those focused on food applications, at 42%.
In terms of geographic breakdown, Catalonia, Madrid, Andalusia and the Basque Country are home to the largest number of companies. Catalonia leads in number of biotech companies in Spain, with almost a quarter of the total and more than 35% of total turnover.
The joint activity of biotech companies generated in 2022 over €19,676 billion in revenue, and generated a gross value added of € 6.8 billion.
The science produced by the Spanish biotechnology sector is excellent and its innovation is patented internationally.
In 2022, Spanish scientific production in biotechnology made up 2.46% of global production and was cited 21% more than the global average. Spain remains ranked ninth in the world in number of papers in biotechnology.
Technological innovation is being protected more and more internationally. Patents through PCT and the European Patent Office make up 82% of all patent applications.
In 2023, we identified 96 new products launched to market by AseBio member companies.
The sector is working together to tackle the pandemic and maintains its interest in international markets.
Biotech firms forged 332 partnerships and 224 of them were with public entities and foundations. R&D is the main goal for companies seeking out strategic partnerships, with this being the main goal in 84% of all partnerships. In terms of country of origin, the number of international partners was up 10% from the previous year.
AseBio member companies increased internationalization 8%, with 16 new subsidiaries. 43 member companies have a direct presence in 59 countries on all continents.
Social perception of Biotechnology in Spain
According to the Survey on Social Perception of Innovation, more than 80% of the population sees innovation as positive, up nearly 8% over the previous year. Plus, public perception still puts Spanish innovation on par with the European Union average.
Public opinion of biotechnology remains the most highly rated factor among AseBio members. On the other hand, the economic situation remains the main barrier in the sector, along with the regulatory framework, which has been negatively affected by changes implemented in 2023.
In 2022, Spanish scientific production in biotechnology made up 2.46% of global production and was cited 21% more than the global average. Spain remains ranked ninth in the world in number of papers in biotechnology.
Technological innovation is being protected more and more internationally. Patents through PCT and the European Patent Office make up 82% of all patent applications. In 2023, we identified 96 new products launched to market by AseBio member companies.
About the host city -region
Catalonia is considered one of the leading life sciences and healthcare innovation hubs across Europe. The so-called “BioRegion” is based on a network of excellent research, a quality higher-education system and a rich network of talent, hospitals, institutions, industry and investors that perform cutting-edge research and provide the sector with innovation and services.
The ecosystem is mostly located in Barcelona and accounts 91 research entities and over 1,400 companies (biotech, pharma, medtech and digital health) that, together with the healthcare services, generate 8 % of the Catalan GDP and employ over 6.5% of the total working population of Catalonia. The region is also ranks third in Europe by number of publications per million inhabitants on advance therapies, and fifth in Europe and eight worldwide by participation in active clinical trials.
According to the prestigious Financial Times Foreign Direct Investment European Cities and Regions of the Future 2022/2023”, Catalonia and Barcelona stand out as the region and the city with the best investment attracting strategy in Europe. The region attracted + € 1,025 million in the sector in 2023.
- days
- hours
- minutes
- seconds
AM Conferences & Meetings